| Similar Articles |
|---|
 |
Nurse Practitioner
June 2011
Eva Hardy |
Gout Diagnosis and Management: What NPs Need to Know Because primary care providers diagnose and treat the vast majority of patients with gout, it is important that they understand current guidelines and evidence-based practice.   |
AskMen.com
Charles Capuano |
Common Foot Ailments Foot-in-mouth disease is frequent among men. Here are some other common problems involving the foot, who's most at risk, and what you can do about them. |
BusinessWeek
September 1, 2009
Catherine Arnst |
Opportunities in the Obesity Epidemic Drugmakers are ratcheting up research into treatments for gout and other ills that plague the overweight. |
Chemistry World
April 26, 2012
Sarah Houlton |
AstraZeneca seeks to refill dry pipeline with gout drug AstraZeneca is to acquire US-based Ardea Biosciences in a deal worth $1.26 billion. Its lead product, lesinurad, moved into Phase III trials at the end of last year for the management of patients suffering from gout. |
American Family Physician
July 1, 2003
Siva et al. |
Diagnosing Acute Monoarthritis in Adults: A Practical Approach Acute monoarthritis can be the initial manifestation of many joint disorders. Because patients with acute monoarthritis often present to their family physician, a proper diagnostic approach is important. |
BusinessWeek
September 3, 2009 |
Beyond Diabetes: Diseases Related to Obesity Four diseases linked to obesity. |
American Family Physician
July 1, 2006
Pietrow & Karellas |
Medical Management of Common Urinary Calculi Certain dietary changes can reduce risk of occurrence of kidney stones. Citrate medications will also increase levels of naturally occurring stone inhibitors. |
Nursing
February 2010
Jeanne Held-Warmkessel |
How to prevent and manage Tumor lysis syndrome Potentially fatal, tumor lysis syndrome is a metabolic disturbance caused by the death of cancer cells during cancer treatment and the release of their intracellular components into the bloodstream. |
The Motley Fool
June 9, 2010
Brian Orelli |
The Drug Passed, but the Stock Fell? Regeneron only bats .500. |
The Motley Fool
February 28, 2011
Brian Orelli |
Look Out for Big Growth From This Drug Regeneron's ultra-orphan drug Arcalyst takes a step forward toward a wider audience. |
American Family Physician
September 15, 2003
Richie & Francis |
Diagnostic Approach to Polyarticular Joint Pain Polyarticular joint pain (i.e., pain in more than four joints) poses a diagnostic challenge because of the extensive differential diagnosis. Consequently, family physicians need to keep the diagnosis open in evaluating patients who present with pain in multiple joints. |
Chemistry World
April 1, 2008
Michael Gross |
Aluminium's Vaccine Boost Explained Researchers based in the Netherlands and Belgium have worked out how aluminium salts, used to boost the effectiveness of vaccines, stimulate the immune system. |
Science News
November 13, 2004
Diana Parsell |
Vegetable Soup Fights Cell Damage Scientists at Tufts University report that volunteers eating a type of vegetable soup twice a day had lower amounts of stress-related molecules in their blood after just 7 days. |
